Skip to content
10-Q

Quarterly Report

NUTRALIFE BIOSCIENCES, INC.

0001493152-21-017022

← back to feed
Filed
Jul 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Jul 16, 2021 163.4M sh
Cash And Equivalents Q1 2021 · Mar 31, 2021 $98.19K
Cash And Equivalents Q1 2021 · Dec 31, 2020 $742
Current Liabilities Q1 2021 · Mar 31, 2021 $3.76M
Current Liabilities Q1 2021 · Dec 31, 2020 $3.78M
Total Liabilities Q1 2021 · Mar 31, 2021 $4.48M
Total Liabilities Q1 2021 · Dec 31, 2020 $4.41M
Current Assets Q1 2021 · Mar 31, 2021 $770.41K
Current Assets Q1 2021 · Dec 31, 2020 $722.46K
Total Assets Q1 2021 · Mar 31, 2021 $4.68M
Total Assets Q1 2021 · Dec 31, 2020 $4.71M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$430.5K
Stockholders Equity Q1 2021 · Mar 31, 2020 $1.08M
Stockholders Equity Q1 2021 · Dec 31, 2019 $1.59M
Net Income Q1 2021 · Mar 31, 2020 −$1.02M
Operating Income Q1 2021 · Mar 31, 2020 −$506.35K
Gross Profit Q1 2021 · Mar 31, 2020 −$75.42K
Revenue Q1 2021 · Mar 31, 2020 $192.05K